Elsa C. Kuijper
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Determining off-target effects of splice-switching antisense oligonucleotides using short read RNAseq in neuronally differentiated human induced pluripotent stem cells.
Journal: Human molecular genetics
Published: July 02, 2025
Calcium-Enhanced Medium-Based Delivery of Splice Modulating Antisense Oligonucleotides in 2D and 3D hiPSC-Derived Neuronal Models.
Journal: Biomedicines
Published: July 08, 2024
Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice.
Journal: Neurobiology of disease
Published: September 08, 2023
Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 25, 2022
Huntington Disease Gene Expression Signatures in Blood Compared to Brain of YAC128 Mice as Candidates for Monitoring of Pathology.
Journal: Molecular neurobiology
Published: May 17, 2021
Opportunities and challenges for antisense oligonucleotide therapies.
Journal: Journal of inherited metabolic disease
Published: January 10, 2020
Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 27, 2019
FcαRI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming.
Journal: Nature communications
Published: February 28, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026